Apoptosis and the thyroid: The Fas/Fas L pathway;Apoptose et thyroïde: Le face à Fas

Presse Medicale

Volumn 30, Issue 2, 2001, Pages 74-80

  Vlaeminck Guillem, V ^a   D'Herbomez Boidein, M ^a   Decoulx, M ^a   Wemeau J L ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; FAS ANTIGEN; FAS LIGAND; PROTEIN BCL 2; THYROTROPIN;

APOPTOSIS; ARTICLE; HASHIMOTO DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTIC INFILTRATION; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; THYROID FUNCTION; THYROID WEIGHT;

ANTIGENS, CD95; APOPTOSIS; GRAVES DISEASE; HUMANS; THYROID GLAND; THYROID NEOPLASMS; THYROIDITIS, AUTOIMMUNE; THYROTROPIN;

EID: 18144450566     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Le système Fas/Fas-ligand: Implications dans la réponse immunitaire antitumorale et dans l'activité des agents cytotoxiques
2. Amphibian metamorphosis as a model for studying the developmental actions of thyroid hormone
3. Fas and Fas ligand in embryos and adult mice: Ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover
4. H202 induces apoptosis of pig thyrocytes in culture
5. Apoptosis by death factor
6. Apoptosis in dog thyroid cells
7. The Fas death factor
8. TRAIL death pathway expression and induction in thyroid follicular cells
9. CD40 stimulation inhibits cell growth and Fas-mediated apoptosis in a thyroid cancer cell line
10. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer
11. FAP-1: A protein tyrosine phosphatase that associates with Fas
12. Inhibition of death receptor signals by cellular FLIP
13. The Fas counterattack: Cancer as a site of immune privilege
14. Expression of the cell death-inducing gene bax in carcinomas developed from the follicular cells of the thyroid gland
15. Human and mouse Fas (APO-1/CD95) death receptor genes each contain a p53-responsive element that is activated by p53 mutants unable to induce apoptosis
16. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells
17. Analysis of apoptosis in relation to tissue destruction associated with Hashimoto's autoimmune thyroiditis
18. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis
19. Dying (apoptosing?) for a consensus on the Fas death pathway in the thyroid
20. The role of Fas-mediated apoptosis in thyroid autoimmune disease
21. Apoptosis in thyroid diseases: A histochemical study
22. Thyroid-stimulating hormone inhibits Fas antigen-mediated apoptosis of human thyrocytes in vitro
23. Fas (APO-1, CD95)-mediated apoptosis in thyroid cells is regulated by a labile protein inhibitor
24. Fas/Fas ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto's thyroiditis
25. Constitutive expression of FasL in thyrocytes
26. Fas ligand expression in thyroid carcinomas: A potential mechanism of immune evasion
27. Functional Fas ligand expression in thyrocytes from patients with Graves' disease
28. Constitutive expression of FasL in thyrocytes
29. Role of apoptosis of thyrocytes in a rat model of goiter. A possible involvement of Fas system
30. Fas-Mediated apoptosis is inhibited by TSH and iodine in moderate concentrations in primary human thyrocytes in vitro
31. Modulation of Fas-mediated apoptosis of human thyroid epithelial cells by IgG from patients with Graves' disease (GD) and idiopathic myxoedema
32. Fas (CD95) expression is up-regulated on papillary thyroid carcinoma
33. Inflammatory cytokine regulation of Fas-mediated apoptosis in thyroid follicular cells
34. Immunohistochemical localization of FAP-1, an inhibitor of Fas-mediated apoptosis, in normal and neoplastic human tissues
35. Characterization of FAP-1 expression and function in thyroid follicular cells
36. Chronic autoimmune thyroiditis
37. Fas-FasL interactons: A common pathogenetic mechanism in organ-specific autoimmunity
38. The role of Fas in autoimmune diabetes
39. Significant role for fas in the pathogenesis of autoimmune diabetes
40. Fas and Fas ligand expression in the salivary glands of patients with primary Sjogren's syndrome
41. Fas/Fas ligand-driven T cell apoptosis as a consequence of ineffective thyroid immunoprivilege in Hashimoto's thyroiditis
42. Fas and Fas ligand gene expression in autoimmune thyroiditis in BB/W rats
43. Intrathyroidal cytokine gene expression in Hashimoto's thyroiditis
44. Gene therapy of experimental autoimmune thyroiditis by in viva administration of plasmid DNA coding for Fas ligand
45. Transgenic expression of Fas ligand on thyroid follicular cells prevents autoimmune thyroiditis
46. Structure of the human APO-1 gene
47. Protection from Fasmediated apoptosis by a soluble form of the Fas molecule
48. Increased serum soluble Fas in patients with Graves' disease
49. Serum concentration of soluble Fas in patients with autoimmune thyroid diseases
50. Possible involvement of Fas-mediated apoptosis in eye muscle tissue from patients with thyroid-associated ophthalmopathy
51. Serum levels of soluble Fas in patients with Graves' ophthalmopathy
52. Does "death receptor" signaling play a role in tumorigenesis and cancer therapy?
53. Fas ligand-induced apoptosis as a mechanism of immune privilege
54. Apoptosis and thyroiditis
55. Induction of apoptosis in the rheumatoid synovium by Fas ligand gene transfer
56. Gene transfer of Fas ligand induces tumor regression in vivo
57. FADD gene therapy for malignant gliomas in vitro and in vivo